Literature DB >> 178330

Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia.

R G Murray, A Tweddel, J L Third, I Hutton, W S Hillis, A R Lorimer, T D Lawrie.   

Abstract

Lipoprotein analyses were performed in 133 male patients and were correlated with the coronary arteriographic findings. The prevalence of hyperlipoproteinaemia was significantly higher in those patients with coronary artery disease (P less than 0-02). In addition, the more extensive the degree of coronary artery pathology the higher were the plasma concentrations of total cholesterol, triglyceride, and low density lipoprotein (LDL) cholesterol. Hyperlipoproteinaemia was more prevalent in the younger patients with coronary artery disease (P less than 0-02).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 178330      PMCID: PMC482942          DOI: 10.1136/hrt.37.12.1205

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

1.  Cine coronary arteriography.

Authors:  F M SONES; E K SHIREY
Journal:  Mod Concepts Cardiovasc Dis       Date:  1962-07

2.  Selective coronary arteriography. I. A percutaneous transfemoral technic.

Authors:  M P Judkins
Journal:  Radiology       Date:  1967-11       Impact factor: 11.105

3.  The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease.

Authors:  A F Salel; K Riggs; D T Mason; E A Amsterdam; R Zelis
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

4.  Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

Authors:  L A Carlson; L E Böttiger
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

5.  Relation between blood lipid levels and angiographically evaluated obstructions in coronary arteries.

Authors:  S Nitter-Hauge; I Enge
Journal:  Br Heart J       Date:  1973-08

6.  Coronary artery occlusion and blood lipids.

Authors:  J J Barboriak; A A Rimm; A J Anderson; F E Tristani; J A Walker; R J Flemma
Journal:  Am Heart J       Date:  1974-06       Impact factor: 4.749

7.  Prevalence of hyperlipoproteinaemia in apparently healthy men.

Authors:  A R Lorimer; F C Cox; D A Greaves; J S Jubb; V M Hawthorne; H G Morgan; T D Lawrie
Journal:  Br Heart J       Date:  1974-02

Review 8.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Clinical significance of the coronary arteriogram.

Authors:  D C Banks; E B Raftery; S Oram
Journal:  Br Heart J       Date:  1971-11

10.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

View more
  6 in total

1.  Hyperlipidaemia in Scotland and the role of drug treatment.

Authors:  J L Third; W F Bremner; T D Lawrie
Journal:  Proc R Soc Med       Date:  1976

2.  HDL cholesterol and coronary artery occlusion.

Authors:  J J Barboriak
Journal:  Br Med J       Date:  1978-09-23

3.  Coronary artery bypass grafting and hyperlipidaemia.

Authors:  G Thompson; R Sapsford
Journal:  Br Heart J       Date:  1985-03

4.  Should studies of patients undergoing coronary angiography be used to evaluate the role of behavioral risk factors for coronary heart disease?

Authors:  T G Pickering
Journal:  J Behav Med       Date:  1985-09

5.  Coronary artery ectasia--a variant of occlusive coronary arteriosclerosis.

Authors:  R H Swanton; M L Thomas; D J Coltart; B S Jenkins; M M Webb-Peploe; B T Williams
Journal:  Br Heart J       Date:  1978-04

6.  Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia.

Authors:  D D Sugrue; G R Thompson; C M Oakley; I M Trayner; R E Steiner
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.